1Herfarth KK,Debus J, Lohr F, et al . Extracranial stereotactic ra-diationtherapy : setup accuracy of patients treated for liver metasta-ses [J] . Int J Radiat Oncol Biol Phys, 2000 , 46(2) : 329-335.
2Lawrence TS ,Robertson JM , Anscher MS,et al . Hepatic toxicityresulting from cancer treatment [ J ] . Int J Radiat Oncol BiolPhys, 1995, 31( 5) : 1237-1248.
3Ben Josef E, Normolle D, Ensminger WD,et al. Phase fl trial ofhigh dose conformal radiation therapy with concurrent hepatic ar-tery floxuridine for unresec table intrahepatic alignancies [ J ]. JClin Oncol, 2005,23(34) :8739-8747.
4Marks LB, Yorke ED, Jackson A, et al. Use of normal tissuecomplication probability models in the clinic [J]. Int J Radiat On-col Biol Phys,2010,76(3) :S10-19.
5Gu K,Lai ST, Ma NY, et al. Hepatic regeneration after sublethalpartial liver irradiation in cirrhotic rats[ J]. J Radiat Res,2011,52(5):582-591.
6Park HJ, Griffin RJ, Hui S, et al. Radiation - induced vasculardamage in tumors : implications of vascular damage in ablative hy-pofraotionated radiotherapy ( SBRT and SRS) [ J ]. Radiat Res,2012,177(3) -.311-327.
7Aoyama H, Shirato H, Tago M,et al. Stereotactic radiosurgery pluswhole - brain radiation therapy vs stereotactic radiosurgery alonefor treatment of brain metastases : a randomized controlled trial[J]. J Am Med Assoc, 2006, 295 :2486-2491.
8Grills I, Mangona V,Welshe R,et al. Outcomes after stereotacticlung radiotherapy or wedge resection for stage I non-small-cell lungcancer[ J]. J Clin Oncol ,2010 , 28 :928-935.
9Kondziolka D, Niranjan A, Flickinger JC,et al. Radiosurgery withor without whole - brain radiotherapy for brain metastases : The pa-tients ’ perspective regarding complications[ J]. Am J Clin Oncol,2005, 28:173-179.
10Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radia-tion therapy for inoperable early stage lung cancer[ J]. J Am MedAssoc ,2010, 303:1070-1076.
4Jian-Dong Zhao,Zhi-Yong Xu,Ji Zhu,et al.Application of activebreathing control in 3-dimensional conformal radiation therapy forhepatocellular carcinoma:The feasibility and benefit. Radiotherapy and Oncology . 2008
5R.V.Tse,Chandan Guha,L.A.Dawson.Conformal radioherapy for hepa-tocellular carcinoma. Critical Reviews in Oncology/Hematology . 2008
6Lax I,Blomgren H,Naslund I,et al.Stereotactic radiotherapy of malignancies in the abdomen, methodological aspects. Acta Oncologica . 1994
3Farinati F, Vanin V, Giacomin A, et al. BCLC stage B hepatocellularcarcinoma and transcatheter arterial chemoembolization :a 20 - yearsurvey by the Italian Liver Cancer group [ J]. Liver Int,2015, 35(1) :223-231.
